| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +15% |
| 3Y CAGR | -3% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +17% |
| 3Y CAGR | -3% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹21,890.00 -15.00 (0.07%) | 28,109.52 | 56.47 | 15 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,835.10 -32.30 (1.13%) | 21,783.43 | 32.13 | 6.46 | ||
PfizerPFIZER | ₹4,000.80 -45.40 (1.12%) | 18,517.08 | 25.19 | 4.41 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,505.00 -86.00 (1.30%) | 16,472.25 | 97.11 | 18.87 |